USP 797, an updated national minimum standard for preparing compounded sterile drugs, went into effect on November 1, 2023. Learn about the purpose of this regulation, the specific requirements it set forth, and how using the right software can help your practice address these regulations.

Hear from Neha Kharod, MD, a board-certified physician who cares for children and adults with asthma, allergic diseases and immunologic disorders, and ModMed® Senior Product Manager Luke Barratt, who has designed and built automation platforms for allergen immunotherapy compounding.